Eco Animal Health Group PLC Result of AGM (7643L)
07 September 2023 - 11:57PM
UK Regulatory
TIDMEAH
RNS Number : 7643L
Eco Animal Health Group PLC
07 September 2023
7 September 2023
ECO Animal Health Group plc ("the Company")
(AIM: EAH)
Result of Annual General Meeting
ECO Animal Health Group plc announces that at its Annual General
Meeting held earlier today ("AGM") all resolutions proposed to the
meeting were duly passed.
Proxy votes received in relation to each resolution were as
follows :
Resolution For % Discretionary % Against % Withheld
01 40,393,039 99.996 Nil 0.000 1,594 0.004 Nil
----------- --------- ---------------- -------- ---------- -------- ---------
02 37,377,701 92.531 3,384 0.008 3,013,548 7.460 Nil
----------- --------- ---------------- -------- ---------- -------- ---------
03 40,386,195 99.979 Nil 0.000 8,187 0.020 251
----------- --------- ---------------- -------- ---------- -------- ---------
04 40,393,039 99.996 Nil 0.000 1,594 0.004 Nil
----------- --------- ---------------- -------- ---------- -------- ---------
05 40,392,788 99.995 Nil 0.000 1,594 0.004 251
----------- --------- ---------------- -------- ---------- -------- ---------
06 40,383,756 99.973 Nil 0.000 5,877 0.014 5,000
----------- --------- ---------------- -------- ---------- -------- ---------
07 40,383,756 99.973 Nil 0.000 5,877 0.014 5,000
----------- --------- ---------------- -------- ---------- -------- ---------
Contacts:
ECO Animal Health Group plc
David Hallas (Chief Executive Officer)
Christopher Wilks (Chief Financial Officer) 020 8447 8899
IFC Advisory
Graham Herring
Zach Cohen 020 3934 6630
Singer Capital Markets (Nominated Adviser &
Joint Broker)
Philip Davies
George Tzimas
Sam Butcher 020 7496 3000
Investec (Joint Broker)
Gary Clarence
Carlo Spingardi
Lydia Zychowska 020 7597 5970
Equity Development
Hannah Crowe
Matt Evans 020 7065 2692
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the "GROUP") researches,
develops and commercialises products for livestock. Our business
strategy is to generate shareholder value by achieving the maximum
sales potential from the existing product portfolio whilst
investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGSSMFDWEDSEIU
(END) Dow Jones Newswires
September 07, 2023 09:57 ET (13:57 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Dec 2024 to Jan 2025
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Jan 2024 to Jan 2025